Antibody FormationArthritis, RheumatoidAutoantibodies
Dr. Lindsay B. Kelmenson, MD
NPI1457647935PAC ID0648432971
- Medicare services, 2024
- 18,803
- Medicare patients, 2024
- 196
- Part D claims, 2024
- 2,328
- Publications
- 11
- MIPS score, 2024
- 70
- Practice address
- 1801 First Ave South, Birmingham, AL 35233
- Practice phone
- Call (205) 581-3500
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Labcorp - Birmingham (1st Ave S)
Clinical Lab - Full Service · Birmingham, Alabama
Find Dr. Kelmenson's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Lindsay B. Kelmenson is a rheumatologist in Birmingham, Alabama
Dr. Kelmenson practices at Labcorp - Birmingham (1st Ave S) in Birmingham, Alabama.
Dr. Kelmenson's NPI, 1457647935, was assigned on June 23, 2011. Dr. Kelmenson graduated from University of Alabama School of Medicine in 2011. Dr. Kelmenson holds Alabama license 36800.
NPI and contact details
- NPI
- 1457647935NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0648432971
- NPI enumeration date
- June 23, 2011
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (205) 581-3500
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 41
- Medical school graduation
- 2011
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Lindsay B. Kelmenson practices at Labcorp - Birmingham (1st Ave S) in Birmingham, Alabama
Dr. Kelmenson's primary practice is Labcorp - Birmingham (1st Ave S), at 1801 First Ave South, Birmingham, AL 35233. The practice phone is (205) 581-3500.
- Labcorp - Birmingham (1st Ave S)1801 First Ave South, Birmingham, AL 35233Phone(205) 581-3500
Source: Dmand AI Affiliation Data
Dr. Lindsay B. Kelmenson is affiliated with 4 sites of care and 1 medical group
Dr. Kelmenson's primary practice is Labcorp - Birmingham (1st Ave S) in Birmingham, Alabama. Dr. Kelmenson is also affiliated with Baptist Health Princeton Hospital. The medical group on file is Rheumatology Care Center. Dmand AI also links Dr. Kelmenson to 1 more hospital and 1 group practice or clinic, each named with a free account.
Labcorp - Birmingham (1st Ave S)Primary
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Lindsay B. Kelmenson's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kelmenson practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Labcorp - Birmingham (1st Ave S) | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Kelmenson practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Lindsay B. Kelmenson is one of 84 rheumatologists in Alabama
Rheumatology is Dr. Kelmenson's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Kelmenson is licensed in Alabama.
Specialties and state licenses
- Rheumatology, AlabamaPrimary
Rheumatologists near Dr. Kelmenson
Counts of rheumatologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Lindsay B. Kelmenson billed Medicare for 18,803 services in 2024
CMS data shows 18,803 Medicare services from Dr. Kelmenson across 13 procedure codes in 2024, for 196 Medicare patients. Medicare paid $526,984 for them. Every service was in an office.
Medicare services, 202418,803
Medicare patients196
Paid by Medicare$526,984
Procedure codes13
Dr. Kelmenson's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 12,7362024: 17,62538%
- Tests and treatments
- 2023: 5102024: 57413%
- Office and hospital visits
- 2023: 4022024: 3913%
- Other services
- 2023: 02024: 198
- Surgery
- 2023: 182024: 1517%
Dr. Kelmenson compared with the Alabama median for rheumatologists, 2024
- Dr. Kelmenson
- Alabama median
- Medicare services
- 18,803vs 2,6607.1 times
- Medicare patients
- 196vs 24821% below
- Part D claims
- 2,102vs 2,3069% below
Medians across 85 rheumatologists in Alabama with Dmand AI profiles that report each measure.
Dr. Kelmenson's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kelmenson?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kelmenson and other rheumatologists in Alabama.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Lindsay B. Kelmenson treated 196 Medicare patients in 2024, average age 71
CMS counts 196 Medicare patients who saw Dr. Kelmenson in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have arthritis, and 75% have high blood pressure. Their average risk score is 1.33, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Kelmenson's median patient age at 57, with 83% women.
Medicare patients, 2024196
Average age71
Average risk score1.33
Dr. Kelmenson's Medicare patients by age, 2024
Dr. Kelmenson's Medicare patients by sex, 2024
- Women16484%
- Men3216%
Chronic conditions among Dr. Kelmenson's Medicare patients, 2024
- Arthritis75%
- High blood pressure75%
- High cholesterol75%
- Osteoporosis38%
- Chronic kidney disease29%
- Anxiety28%
- Mood disorders24%
- Ischemic heart disease22%
Share of Medicare patients with each condition. A patient can have several.
Dr. Kelmenson's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 57
Patient panel by sex, all payers
- Women83%
- Men17%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Lindsay B. Kelmenson wrote 2,328 Medicare Part D claims in 2024
In 2024, Dr. Kelmenson wrote 2,328 Medicare Part D claims for 246 patients. 92% of them were for generic drugs. CMS names the drug for 2,102 of them, across 32 drugs with 11 or more claims each, at $463,244 in total drug cost. In 2023, CMS named 1,796 claims across 31 drugs.
Part D claims, 20242,328
Drugs named by CMS32
Total drug cost$463,244
Part D patients246
Dr. Kelmenson's Part D claims by kind of drug, 2024
- Generic2,149 claims92%
- Brand-name and other179 claims8%
Dr. Kelmenson's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Kelmenson's Part D claims, 2024
- Opioids2%49 of 2,328 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,7962024: 2,10217%
Drugs named by CMS: 32 in 2024, 31 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Lindsay B. Kelmenson scored 70 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 70 out of 100 for Dr. Kelmenson for performance year 2024, reported as part of a group. Dr. Kelmenson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Kelmenson's MIPS scores, performance year 2024
- 70of 100Final score
- 75.3of 100Quality
- 40of 100Improvement Activities
- 32of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find rheumatologists like Dr. Kelmenson by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Lindsay B. Kelmenson has 11 publications on record
Dmand AI links 11 papers to Dr. Kelmenson, published from 2016 to 2023. 2019 was the busiest year, with 2. The most frequent topics are Arthritis, Rheumatoid, Autoantibodies and Rheumatoid Factor. Dr. Kelmenson has published most often in Arthritis Rheumatol. Dr. Kelmenson's most frequent co-authors are Kevin Deane, MD, Jess David Edison, MD and V Michael Holers, MD.
Papers11
Years published2016 to 2023
Dr. Kelmenson's papers by year, 2016 to 2023
Topics Dr. Kelmenson writes about most
- Arthritis, Rheumatoid
- Autoantibodies
- Rheumatoid Factor
- Anti-Citrullinated Protein Antibodies
- Immunoglobulin A
- Immunoglobulin M
- Military Personnel
Dr. Kelmenson's most frequent co-authors
- Kevin Deane, MD11 shared papers
- Jess David Edison, MD6 shared papers
- V Michael Holers, MD5 shared papers
Recent publications by Dr. Kelmenson
Semin Arthritis Rheum
Antibodies, BacterialArthritis, RheumatoidAutoantibodies
Amino AcidsArthritis, RheumatoidMilitary Personnel
Arthritis Rheumatol
AcetaldehydeAnti-Citrullinated Protein AntibodiesArthritis, Rheumatoid
See who Dr. Kelmenson researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kelmenson works with, so you can find a warm path to the right rheumatologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Lindsay B. Kelmenson received $19,593 in industry payments from 2018 to 2025
CMS Open Payments shows 1,055 general payments to Dr. Kelmenson from 38 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $4,057.
General payments to Dr. Kelmenson by program year, 2018 to 2025
General payments to Dr. Kelmenson by kind, 2018 to 2025
$19.6Kin total
- Food and beverage$19,04697%
- Consulting fees$5003%
- Education$470%
Companies that paid Dr. Kelmenson the most, 2018 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Lindsay B. Kelmenson graduated from University of Alabama School of Medicine
Dr. Kelmenson graduated from University of Alabama School of Medicine in 2011.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Lindsay B. Kelmenson's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Lindsay B. Kelmenson
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Lindsay B. Kelmenson's NPI number?
Dr. Lindsay B. Kelmenson's NPI number is 1457647935. It was assigned on June 23, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Lindsay B. Kelmenson?
Dr. Lindsay B. Kelmenson is a rheumatologist in Birmingham, Alabama. The primary specialty in the NPI Registry is Rheumatology Physician (taxonomy code 207RR0500X).
Where does Dr. Lindsay B. Kelmenson practice?
Dr. Kelmenson practices at 1801 First Ave South, Birmingham, AL 35233. Dr. Kelmenson's primary practice is Labcorp - Birmingham (1st Ave S) in Birmingham, Alabama. Dmand AI also links Dr. Kelmenson to 1 hospital and 1 group practice or clinic.
What is Dr. Lindsay B. Kelmenson's office phone number?
The practice phone on file for Dr. Kelmenson is (205) 581-3500.
What is Dr. Lindsay B. Kelmenson's medical license number?
Dr. Kelmenson holds Alabama license 36800.
Which hospitals is Dr. Lindsay B. Kelmenson affiliated with?
Dr. Kelmenson is affiliated with Baptist Health Princeton Hospital. Dmand AI links Dr. Kelmenson to 1 more hospital.
What medical group is Dr. Lindsay B. Kelmenson part of?
Dr. Kelmenson is linked to Rheumatology Care Center.
Does Dr. Lindsay B. Kelmenson accept Medicare?
Yes. CMS data shows Dr. Kelmenson billed Medicare for 18,803 services in 2024, and Dr. Kelmenson accepts Medicare assignment.
What is Dr. Lindsay B. Kelmenson's MIPS score?
Dr. Kelmenson's MIPS final score for performance year 2024 is 70 out of 100, reported as part of a group.
How many Medicare patients does Dr. Lindsay B. Kelmenson see?
CMS counts 196 Medicare patients who saw Dr. Kelmenson in 2024, with an average age of 71.
Show 7 more questionsShow fewer questions
What services does Dr. Lindsay B. Kelmenson bill to Medicare?
In 2024, Dr. Kelmenson's most billed Medicare services were injected or infused drug (J0129), injected or infused drug (J0897) and injected or infused drug (J1010).
Where did Dr. Lindsay B. Kelmenson go to medical school?
Dr. Kelmenson graduated from University of Alabama School of Medicine in 2011.
What drugs does Dr. Lindsay B. Kelmenson prescribe most?
In 2024 Medicare Part D data, Dr. Kelmenson's most prescribed drugs by claims were Hydroxychloroquine Sulfate, Methotrexate and Prednisone.
Has Dr. Lindsay B. Kelmenson received payments from drug or device companies?
CMS Open Payments shows $19,593 in general payments to Dr. Kelmenson from 38 companies from 2018 to 2025. The largest total came from Abbvie Inc.
How long has Dr. Lindsay B. Kelmenson been practicing?
Dr. Kelmenson graduated from medical school in 2011, 15 years ago.
Does Dr. Lindsay B. Kelmenson do research?
Dmand AI links 11 publications to Dr. Kelmenson, published from 2016 to 2023.
Who does Dr. Lindsay B. Kelmenson publish with?
Dr. Kelmenson's most frequent co-authors are Kevin Deane, MD (11 shared papers), Jess David Edison, MD (6 shared papers) and V Michael Holers, MD (5 shared papers).
Selling to rheumatology practices?
See rheumatologists in Alabama by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card